Neuropsychiatrie, Decouverte & Innovation Inc. (NDEI)

NDEI, a spin-off company of the Centre de recherche Universite Laval Robert-Giffard (CRULRG) is in the foreground of psychiatric genomic research. Our mission is: to perform genetic and medical research to identify disease genes, and drug and diagnostic targets for neuropsychiatric disorders, particularly schizophrenia and bipolar disorders; to use modern informatics technology to discover facts about mental health and neuropsychiatric disease through the use of extensive clinical and DNA banks and longitudinal access, established over the past 12 years, with the Eastern Quebec population and its psychiatric clinical network; to use this knowledge to develop products and services for the international mental healthcare industry. NDEI was founded in 2002 and is based in Quebec City, Canada.